title: Correlation between HIV provirus burden and in utero transmission.
abstract: OBJECTIVE
  No predictive parameters of in utero or perinatal vertical transmission of HIV to newborns are known at present. Vertical transmission may be related to several biological parameters of maternal HIV infection: (1) immunological parameters (neutralizing antibodies); (2) the concentration of viral particles and/or infected cells; and (3) the selection of HIV subspecies of particular cellular tropism. The present study was designed to examine the relationship between cellular viral burden and transmission, and between maternal viral burden and CD4+ cell count and clinical status at delivery.
  
  
  METHODS
  We investigated mother-to-infant HIV-1 transmission at delivery in a cohort of 51 pairs of mothers and newborns. Twelve infants were HIV-infected, as determined by successive polymerase chain reaction and culture determinations within the first 6 months of life, and nine of these were diagnosed as HIV-infected during the first week of life. We determined peripheral blood mononuclear cell proviral DNA burden using a quantitative polymerase chain reaction assay. Polymerase chain reaction was performed in the HIV-1 gag gene, using [32P]-end-labelled primers. External standard DNA samples were from the 85-14 F2 cell line, which contains a unique defective proviral DNA genome.
  
  
  RESULTS
  There was a linear relationship between the logarithms of c.p.m. and the number of HIV-1 DNA copies.
  
  
  CONCLUSIONS
  We have previously reported that the number of HIV provirus copies in maternal blood cells is related to transmission of the virus. Quantification of the HIV provirus by polymerase chain reaction may be used as a predictive parameter of vertical transmission if accompanied by an exhaustive clinical and biological follow-up during pregnancy.
authors.affiliation: Laboratory for Experimental Neuropathology and Neurovirology, CEA/CRSSA, DSV/DPTE, Fontenay aux Roses, France.
authors.forename: P
authors.initials: P
authors.lastname: Roques
authors.forename: D
authors.initials: D
authors.lastname: Marce
authors.forename: C
authors.initials: C
authors.lastname: Courpotin
authors.forename: F P
authors.initials: FP
authors.lastname: Mathieu
authors.forename: F
authors.initials: F
authors.lastname: Herve
authors.forename: F D
authors.initials: FD
authors.lastname: Boussin
authors.forename: R
authors.initials: R
authors.lastname: Narwa
authors.forename: M C
authors.initials: MC
authors.lastname: Meyohas
authors.forename: C
authors.initials: C
authors.lastname: Dollfus
authors.forename: D
authors.initials: D
authors.lastname: Dormont
mesh_terms: D001483:Base Sequence; D015496:CD4-Positive T-Lymphocytes; D017931:DNA Primers / Q000235:genetics; D004279:DNA, Viral / Q000097:blood / Q000235:genetics; D005260:Female; D015658:HIV Infections / Q000150:complications* / Q000382:microbiology / Q000635:transmission*; D015497:HIV-1 / Q000235:genetics / Q000302:isolation & purification*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007958:Leukocyte Count; D008431:Maternal-Fetal Exchange; D008969:Molecular Sequence Data; D016133:Polymerase Chain Reaction; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000097:blood / Q000276:immunology / Q000382:microbiology*; D011533:Proviruses / Q000235:genetics / Q000302:isolation & purification*; D012307:Risk Factors
chemical_list: D017931:DNA Primers; D004279:DNA, Viral